Risk indicator taxonomy for supervision of clinical trials on medicinal products.

CONCLUSIONS: We identified a wide array of risk indicators for clinical trials on medicinal products and we used a tree-structure to incorporate the indicators identified to clearly distinguish individual indicators and to enable efficient use of the indicators. The overview of indicators may facilitate multiple stakeholders in developing structured risk assessment (identification and analysis) for supervising clinical trials on medicinal products. Stakeholders can interpret and prioritise the indicators from their own perspective. PMID: 27009363 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research